Literature DB >> 7544229

Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum.

A Müllbacher1, M Lobigs.   

Abstract

Flavivirus infection of mammalian cells increases the cell surface expression of major histocompatibility complex (MHC) class I molecules, the recognition elements for cytotoxic T cells. Here, we show that the mechanism for flavivirus-induced up-regulation of class I MHC involves an increase in peptide supply to the endoplasmic reticulum. Flavivirus-mediated peptide supply for MHC class I assembly is independent of the peptide transporters for class I antigen presentation, since infection of class I MHC peptide transport-deficient cell lines with flaviviruses results in the cell surface expression of biologically functional class I MHC peptide complexes. The flavivirus-induced supply of antigenic peptides to the endoplasmic reticulum is not restricted to flavivirus-encoded peptides and independent of interferon. The data imply that peptide availability regulates surface expression of class I MHC restriction elements and suggests a mechanism for flavivirus-induced immunopathology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544229     DOI: 10.1016/1074-7613(95)90090-x

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  25 in total

1.  Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection.

Authors:  F Momburg; A Müllbacher; M Lobigs
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 2.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 3.  Cytotoxic T cells and viral hepatitis.

Authors:  F V Chisari
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice.

Authors:  Rosa M Licon Luna; Eva Lee; Arno Müllbacher; Robert V Blanden; Rod Langman; Mario Lobigs
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines.

Authors:  J Shen; S S T-To; L Schrieber; N J King
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis.

Authors:  D H Libraty; S Pichyangkul; C Ajariyakhajorn; T P Endy; F A Ennis
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 7.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

8.  Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide.

Authors:  Nathan R Martinez; Petra Augstein; Antonis K Moustakas; George K Papadopoulos; Silvia Gregori; Luciano Adorini; David C Jackson; Leonard C Harrison
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

9.  Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity.

Authors:  Kerstin Herzer; Christine S Falk; Jens Encke; Sören T Eichhorst; Axel Ulsenheimer; Barbara Seliger; Peter H Krammer
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.

Authors:  Saghar Kaabinejadian; Curtis P McMurtrey; Sojung Kim; Rinki Jain; Wilfried Bardet; Fredda B Schafer; Jason L Davenport; Aaron D Martin; Michael S Diamond; Jon A Weidanz; Ted H Hansen; William H Hildebrand
Journal:  J Immunol       Date:  2016-04-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.